Patel Dinesh V PH D's Form 4 filing
Protagonist Therapeutics, IncPTGX · filed Jul 23, 2025
- Accession no.
- 0001104659-25-070104
- Filed
- Jul 23, 2025
- Trade date
- Jul 21-23, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions. Open-market sales total $2.88M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Patel Dinesh V PH DCIK 0001120477 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 21, 2025 | Common Stock | AGrant or awardAcquired | +25,000 | $0.00 | $0 | 583,462 | Direct | |
| Jul 21, 2025 | Common Stock | SSaleDisposed | −12,859 | $54.86 | −$705,444.74 | 570,603 | Direct | |
| Jul 22, 2025 | Common Stock | SSaleDisposed | −22,065 | $55.05F3 | −$1,214,678.25 | 548,538 | Direct | |
| Jul 23, 2025 | Common Stock | SSaleDisposed | −17,520 | $54.79F4 | −$959,920.8 | 531,018 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $55.00 to $55.19. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F4
The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $54.75 to $55.00. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.